Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline rich 23 domain containing 1 pseudogene" is a genomic DNA segment that has sequence similarity to the functional PRR23 gene family but is classified as a **pseudogene**, which means it is generally regarded as nonfunctional and does not produce a functional protein[4]. Pseudogenes arise through duplication or retrotransposition of protein-coding genes, but usually accumulate disabling mutations that render them transcriptionally inactive or incapable of translation. There is no evidence supporting a functional or pathological role for this pseudogene, and it is not a molecular target in drug discovery or therapy. Pseudogenes are typically not expressed as proteins and lack regulatory features necessary for normal gene function[4]. Some pseudogenes may exhibit low-level transcription, or in rare cases, regulatory roles (e.g., as non-coding RNAs), but for ENSG00000285862 specifically, there is no such evidence or functional annotation[4][2]. PRR23D3P is a related pseudogene from the gene family but is distinct (and still classified as a pseudogene with no function or disease association)[3]. No drugs, biomarkers, or mechanisms of action are linked to this entity. If your intention was to identify a druggable receptor or enzyme, this entry does not represent such a target, and its use as a therapeutic endpoint is incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline rich 23 domain containing 1 pseudogene.